Contineum Therapeutics, Inc. (CTNM)
NASDAQ: CTNM · Real-Time Price · USD
11.92
+1.06 (9.76%)
At close: Sep 26, 2025, 4:00 PM EDT
11.42
-0.50 (-4.19%)
After-hours: Sep 26, 2025, 7:33 PM EDT
Contineum Therapeutics Market Cap
Contineum Therapeutics has a market cap or net worth of $334.26 million as of September 26, 2025. Its market cap has decreased by -27.41% in one year.
Market Cap
334.26M
Enterprise Value
164.53M
1-Year Change
-27.41%
Ranking
Category
Stock Price
$11.92
Market Cap Chart
Since the IPO on April 5, 2024, Contineum Therapeutics's market cap has decreased from $402.09M to $334.26M, a decrease of -16.87%. That is a compound annual growth rate of -11.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 26, 2025 | 334.26M | -11.49% |
| Dec 31, 2024 | 377.64M | -6.08% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 650.45B |
| Johnson & Johnson | 432.80B |
| AbbVie | 389.72B |
| UnitedHealth Group | 311.62B |
| Novo Nordisk | 242.68B |
| Novartis AG | 238.65B |
| Abbott Laboratories | 232.44B |
| AstraZeneca | 228.75B |